advertisement

---

Lambert SR 10

Showing records 1 to 10 | Display all abstracts from Lambert SR

86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Wilson ME
American Journal of Ophthalmology 2020; 216: 147-155

---

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Ma X; Ning K
European Journal of Ophthalmology 2020; 0: 1120672120920544

---

86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Trivedi RH
American Journal of Ophthalmology 2020; 216: 147-155

---

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Jabbehdari S
European Journal of Ophthalmology 2020; 0: 1120672120920544

---

86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Weakley DR; Cotsonis GA
American Journal of Ophthalmology 2020; 216: 147-155

---

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Prosseda PP
European Journal of Ophthalmology 2020; 0: 1120672120920544

---

86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Lambert SR
American Journal of Ophthalmology 2020; 216: 147-155

---

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Hu Y
European Journal of Ophthalmology 2020; 0: 1120672120920544

---

86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study

American Journal of Ophthalmology 2020; 216: 147-155

---

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Shue A; Lambert SR; Sun Y
European Journal of Ophthalmology 2020; 0: 1120672120920544

---